Continued Elevation of Plasma IL-4 and IL-17 Predicts the Progression from VMC to DCM.

Zhaohui Wang Yuhua LiaoJ YuanX J JinM YuR Z ChenD J XuJ WeiJ WanD C ZhaoH Y HanB LiGang TianG HuJ Xu

Published in: Disease markers (2020)

The continued elevation of plasma IL-4 and IL-17 in VMC patients were associated with a high incidence of DCM at three months, and these two cytokines were independent predictors for the progression from VMC to DCM.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
risk factors
prognostic factors
patient reported outcomes
patient reported